Reuters -- Belgian biotechnology company Galapagos plans to develop its own products at its own cost and risk in a "important change of strategy", its Chief Executive told a Dutch daily on Tuesday.
Reuters -- Belgian biotechnology company Galapagos plans to develop its own products at its own cost and risk in a "important change of strategy", its Chief Executive told a Dutch daily on Tuesday.
